CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option.

ABSTRACT: The pervasive application of chimeric antigen receptor (CAR)-based cellular therapies in the treatment of oncological diseases has long been recognized. However, CAR T cells can target and eliminate autoreactive cells in autoimmune and immune-mediated diseases. By doing so, they can contribute to an effective and relatively long-lasting remission. In turn, CAR Treg interventions may have a highly effective and durable immunomodulatory effect via a direct or bystander effect, which may have a positive impact on the course and prognosis of autoimmune diseases. CAR-based cellular techniques have a complex theoretical foundation and are difficult to implement in practice, but they have a remarkable capacity to suppress the destructive functions of the immune system. This article provides an ov

SUBMITTER: Muzes G 

PROVIDER: S-EPMC10252902 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature